Artificially synthesizing genomes has broad prospects in fields such as medical research and industrial strains. From the synthesis of the artificial life JCVI-syn1.0 by Craig Venter's team in 2010, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback